Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma

被引:0
|
作者
Yue, Dezhi [1 ]
Ren, Congzhe [1 ]
Li, Hu [2 ]
Liu, Xiaoqiang [1 ]
机构
[1] Tianjin Med Univ, Gen Hosp, Dept Urol, Tianjin 300000, Peoples R China
[2] Shanxian Cent Hosp, Dept Urol, Heze, Shandong, Peoples R China
关键词
clear cell renal cell carcinoma; nomogram; PANoptosis; risk score; signature; CANCER; NECROPTOSIS; APOPTOSIS; PROLIFERATION; INFLAMMASOME; PYROPTOSIS; CASPASE-8;
D O I
10.1097/MD.0000000000039874
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PANoptosis has been shown to play an important role in tumorigenesis and gain more attention. Yet, the prognostic significance of PANoptosis-related genes has not been investigated more in clear cell renal cell carcinoma (ccRCC). The aim of this research was designed to identify and create a signature of PANoptosis-related genes which was expected to predict prognosis of ccRCC more effectively. The transcriptome data and clinical information were collected from The Cancer Genome Atlas database and the Gene Expression Omnibus database. Optimal differentially expressed PANoptosis-related genes, which were closely associated with prognosis and employed to construct a risk score, were extracted by univariate Cox analysis, least absolute shrinkage and selection operator Cox regression and multivariate Cox analysis. We performed Kaplan-Meier survival analysis and time-dependent receiver operating characteristic curves to complete this process. By adopting univariate and multivariate analysis, the constructed risk score was assessed to verify whether it could be taken as an independent contributor for prognosis. Moreover, we created a nomogram in order to predict overall survival (OS) of ccRCC. Five differentially expressed PANoptosis-related genes were screened out and used to construct a risk score. Our results showed that ccRCC patients with high risk score had a poor prognosis and shorter OS. The results of Kaplan-Meier curves and the area under the receiver operating characteristic curves of 1-, 3-, and 5-year OS indicated that the prediction performance was satisfactory. Additionally, the risk model could be taken as an independent prognostic factor in training and validation cohorts. The nomogram exhibited excellent reliability in predicting OS, which was validated by calibration curves. We identified 5 PANoptosis-related genes, which were used to construct a risk score and a nomogram for prognostic prediction with reliable predictive capability. The present study may provide new potential therapeutic targets and precise treatment strategies for ccRCC.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma
    Cheng, Fajuan
    Zheng, Bin
    Wang, Jianwei
    Zhao, Guiting
    Yao, Zhongshun
    Niu, Zhihong
    He, Wei
    CANCER MEDICINE, 2021, 10 (18): : 6503 - 6514
  • [42] Identification of Novel Glycolysis-Related Gene Signatures Associated With Prognosis of Patients With Clear Cell Renal Cell Carcinoma Based on TCGA
    Wu, Chengjiang
    Cai, Xiaojie
    Yan, Jie
    Deng, Anyu
    Cao, Yun
    Zhu, Xueming
    FRONTIERS IN GENETICS, 2020, 11
  • [43] Novel immune-related signature based on immune cells for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma
    Zhou, Libin
    Fang, Hualong
    Yin, Min
    Long, Huimin
    Weng, Guobin
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (06)
  • [44] Construction of a PANoptosis-related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Ovarian Cancer
    Li, Yonghong
    Lyu, Guizhen
    CURRENT MEDICINAL CHEMISTRY, 2024,
  • [45] The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma
    Zhou, Yongying
    Wang, Xiao
    Zhang, Weibing
    Liu, Huiyong
    Liu, Daoquan
    Chen, Ping
    Xu, Deqiang
    Liu, Jianmin
    Li, Yan
    Zeng, Guang
    Li, Mingzhou
    Wu, Zhonghua
    Zhang, Yingao
    Wang, Xinghuan
    DiSanto, Michael E.
    Zhang, Xinhua
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [46] Construction of a novel gene-based model for prognosis prediction of clear cell renal cell carcinoma
    Zhang, Zedan
    Lin, Enyu
    Zhuang, Hongkai
    Xie, Lu
    Feng, Xiaoqiang
    Liu, Jiumin
    Yu, Yuming
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [47] Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma
    Luo, Gang
    Wang, Lini
    Zheng, Ziyu
    Gao, Baobao
    Lei, Chong
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [48] A Novel m6A Gene Signature Associated With Regulatory Immune Function for Prognosis Prediction in Clear-Cell Renal Cell Carcinoma
    Chen, Siteng
    Zhang, Ning
    Zhang, Encheng
    Wang, Tao
    Jiang, Liren
    Wang, Xiang
    Zheng, Junhua
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 8
  • [49] Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification
    Ouyang, Guoqing
    Li, Qiuyun
    Wei, Yangnian
    Dai, Wenbin
    Deng, Haojian
    Liu, Youli
    Li, Jiaguang
    Li, Mingjuan
    Luo, Shunwen
    Li, Shuang
    Liang, Yunying
    Pan, Guandong
    Yang, Jianqing
    Gan, Tao
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [50] A 17-Gene Expression Signature for Early Identification of Poor Prognosis in Clear Cell Renal Cell Carcinoma
    Bassanelli, Maria
    Borro, Marina
    Roberto, Michela
    Giannarelli, Diana
    Giacinti, Silvana
    Di Martino, Simona
    Ceribelli, Anna
    Russo, Andrea
    Aschelter, Annamaria
    Scarpino, Stefania
    Montori, Andrea
    Pescarmona, Edoardo
    Tomao, Silverio
    Simmaco, Maurizio
    Cognetti, Francesco
    Milella, Michele
    Marchetti, Paolo
    CANCERS, 2022, 14 (01)